Pharma in review: trending stories 10/18/19

Oct 18, 2019

number1

FDA hits Lupin, Aurobindo, Cipla with Form 483s

The FDA found issues related to cleanliness, out-of-specification results and more.


number2PhRMA lashes out against Pelosi drug pricing bill
The lobbying group has warned that Pelosi's bill to lower drug prices would have a “devastating” effect.

number3FDA calls out Torrent as key contributor to major recall

The FDA has issued a warning letter to Torrent Pharmaceuticals.

number4

Sanofi opens next-generation biologics plant in MA

Sanofi has now opened a new digital manufacturing facility in Framingham.

number5

BeiGene builds China biopharma base

BeiGene announced the completion of Phase 1 of a more than 1,000,000 square foot bio facility.